119 related articles for article (PubMed ID: 23732943)
1. Recent approaches for the synthesis of modified cryptophycins.
Weiss C; Sammet B; Sewald N
Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943
[TBL] [Abstract][Full Text] [Related]
2. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
Eissler S; Bogner T; Nahrwold M; Sewald N
Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
[TBL] [Abstract][Full Text] [Related]
3. Efficient and versatile stereoselective synthesis of cryptophycins.
Mast CA; Eissler S; Stoncius A; Stammler HG; Neumann B; Sewald N
Chemistry; 2005 Aug; 11(16):4667-77. PubMed ID: 15915529
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of a new class of cryptophycins based tubulin inhibitors.
Kumar A; Kumar M; Sharma S; Guru SK; Bhushan S; Shah BA
Eur J Med Chem; 2015 Mar; 93():55-63. PubMed ID: 25647428
[TBL] [Abstract][Full Text] [Related]
5. Approaches for the synthesis of functionalized cryptophycins.
Sammet B; Bogner T; Nahrwold M; Weiss C; Sewald N
J Org Chem; 2010 Oct; 75(20):6953-60. PubMed ID: 20857920
[TBL] [Abstract][Full Text] [Related]
6. Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting.
Weiss C; Figueras E; Borbely AN; Sewald N
J Pept Sci; 2017 Jul; 23(7-8):514-531. PubMed ID: 28661555
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of cryptophycin analogues via a scaffold approach.
McCubbin JA; Maddess ML; Lautens M
Org Lett; 2006 Jul; 8(14):2993-6. PubMed ID: 16805535
[TBL] [Abstract][Full Text] [Related]
8. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
Shih C; Teicher BA
Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
[TBL] [Abstract][Full Text] [Related]
9. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
[TBL] [Abstract][Full Text] [Related]
10. Three new cryptophycins from Nostoc sp. GSV 224.
Subbaraju GV; Golakoti T; Patterson GM; Moore RE
J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
[TBL] [Abstract][Full Text] [Related]
11. Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis.
Nahrwold M; Weiß C; Bogner T; Mertink F; Conradi J; Sammet B; Palmisano R; Royo Gracia S; Preuße T; Sewald N
J Med Chem; 2013 Mar; 56(5):1853-64. PubMed ID: 23387527
[TBL] [Abstract][Full Text] [Related]
12. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
[TBL] [Abstract][Full Text] [Related]
13. The cryptophycins: their synthesis and anticancer activity.
Eggen M; Georg GI
Med Res Rev; 2002 Mar; 22(2):85-101. PubMed ID: 11857635
[TBL] [Abstract][Full Text] [Related]
14. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
[TBL] [Abstract][Full Text] [Related]
15. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity studies of new cryptophycin analogues.
Liu WL; Zhang JC; Jiang FQ; Fu L
Arch Pharm (Weinheim); 2009 Oct; 342(10):577-83. PubMed ID: 19714674
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
Ding Y; Seufert WH; Beck ZQ; Sherman DH
J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
[TBL] [Abstract][Full Text] [Related]
18. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
[TBL] [Abstract][Full Text] [Related]
19. Bridging the maytansine and vinca sites: Cryptophycins target β-tubulin's T5-loop.
Abel AC; Mühlethaler T; Dessin C; Schachtsiek T; Sammet B; Sharpe T; Steinmetz MO; Sewald N; Prota AE
J Biol Chem; 2024 May; 300(6):107363. PubMed ID: 38735475
[TBL] [Abstract][Full Text] [Related]
20. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
Mitra A; Sept D
Biochemistry; 2004 Nov; 43(44):13955-62. PubMed ID: 15518544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
